PATENT CLAIM ANALYSIS

Application Number: 16200508
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "044000"]

Abstract:
Treatment of tumors, especially breast cancer or glioblastoma tumors, by silencing RAB27A and/or TRAF3IP2, compositions and methods for same.

Claim (Index 17):
The method of  claim 16 , wherein said silencer is an siRNA, an miRNA, an shRNA, an antisense RNA, or an antisense oligonucleotide.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 98.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14814130', '12792413', '14367926', '14239120', '14919448']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.719856191675571
- 35 USC 102 Novelty (BERT): 0.6342332575522933
- Combined Prediction Score: 0.7112938982632433
- Mean Citation Score: 351.342546
- Max Citation Score: 704.4082599999997
- Similarity Product: 500.1555869055604

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test